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ABSTRACT
Diabetic nephropathy is one of diabetic complications characterized by proteinuria and 
impaired renal function. Confirmation of diagnosis based either on urine value of albumin 
excretion rate (AER) 30-300 mg/24 hours or albumin creatinine ratio (ACR) 30-300 
mg/g or total protein creatinine ratio (TPCR) 150-500 mg/g. It is reported that TPCR 
measurement is more acceptable since it is convenient, fast and does not require special 
preparation. The aim of this study was to investigate the accuracy of TPCR for diagnosis 
of diabetic nephropathy among patients with type 2 diabetes (type 2 DM). A diagnostic 
test study was conducted which involved 86 patients with type 2 DM where urine TPCR 
value equal or more than 150mg/g was independently and blindly compared with AER 
as a refference standard to diagnose diabetic nephopathy. The inclusion criteria were 
patients with type 2 DM who suspected suffer from diabetic nephropathy (suffer from 
DM more than 4 years) and agree to participate in this study. Those whom were suffer 
from at least on of the following diseases urinary tract infection, congestive heart failure, 
liver dysfunction, pregnancy, multiple myeloma, microangiopathy hemolytic anemia 
(MAHA) and incomplete data were excluded from the study. Contingency (2x2) table 
analysis was used to calculate sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV), likelihood ratio for positive test result/LR(+), likelihood 
ratio for negative test result/ LR(-), and accuracy. The average of TPCR among diabetic 
nephropathy patient was 248.07 mg/g. It was significantly higher than compared to 
those non diabetic nephropathy patient (103.52 mg/g). It was found 75 true positive, 
9 true negative, and 2 false positive. The result showed that TPCR had a sensitivity, 
specificity, PPV, and NPV of 97.4%, 100%, 100%, and 81,8% respectively to diagnose 
diabetic nephropathy.The TPCR with value equal or more than 150 mg/g in the morning 
sample urine can be used to diagnose diabetic nephropathy.
ABSTRAK
Nefropati diabetik merupakan salah satu komplikasi diabetes yang ditandai dengan adanya 
proteinuria dan gangguan fungsi ginjal. Konfirmasi diagnosis didasarkan pada laju ekskresi 
albumin (AER) 30-300 mg/24 jam atau rasio kreatinin albumin (ACR) 30-300 mg/g 
atau rasio kreatinin protein total (TPCR) 150-500 mg/g. Pengukuran TPCR lebih dapat 
diterima karena lebih mudah, cepat dan tidak memerlukan persiapan khusus. Penelitian ini 
bertujuan untuk mengkaji akurasi TPCR sebagai penentu diagnosis nefropati diabetik pada 
pasien dengan diabetes melitus tipe 2 (DM tipe2). Studi ini merupakan studi tes diagnostik 
dengan melibatkan 86 pasien DM tipe 2 dengan kadar TPCR urin sama atau lebih dari 
150 mg/g yang secara independen atau buta (blindly) dibanding dengan AER sebagai 
rujukan standar untuk diagnosis nefropati diabetik. Kriteria inklusi adalah pasien DM tipe 
2 yang diduga mengidap nefropati diabetik (menderita DM lebih dari 4 tahun) dan setuju 
untuk berpartisipasi dalam penelitian ini. Pasien yang setidaknya memiliki penyakit seperti 
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infeksi saluran kencing, gagal jantung kongesti, disfungsi hati, hamil, myeloma multipel, 
microangyopathy anemia hemolitik (MAHA) dan data yang tidak lengkap tidak termasuk 
dalam kriteria eksklusi. Analisis tabel kontingensi (2x2) digunakan untuk menghitung 
sensitifitas, spesifisitas, nilai prediktif positif (NPP), nilai prediktif negatif (NPN), rasio 
kemungkinan positif (RK+), rasio kemungkinan negatif (RK-), dan akurasi. Rerata TPCR 
di antara pasien nefropati diabetik sebesar 248,07 mg/g dan lebih tinggi secara bermakna 
dibanding pasien yang tidak menderita nefropati diabetik (103,52 mg/g), serta ditemukan 
75 positif benar, 9 negatif benar, dan 2 positif palsu. Hasil pemeriksaan menunjukkan 
bahwa TPCR memiliki sensitifitas 97,4%, spesifisitas 100%, NPP 100%, dan NPN 81,8% 
untuk diagnosis nefropati diagnostik. TPCR dengan nilai sama atau lebih dari 150 mg/g 
pada sampel urin pagi dapat digunakan untuk diagnosis nefropati diabetik.
Keywords: diabetic nephropathy - total protein creatinine ratio – sensitivity - albumin 
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INTRODUCTION 
Diabetes mellitus (DM) is a group 
of metabolic diseases characterized by 
hyperglycemia due to defects in insulin 
secretion, insulin action, or both. Diabetes 
mellitus is a global health problem since 
its incidence is rising consistently for all 
age-groups worldwide.1,2 In 2014, WHO 
estimated that 422 million adults aged over 18 
years in the world were living with DM. The 
prevalence of DM in South East Asia region 
increased from 17 million (4.1%) in 1980 
to 96 million (8.6%) in 2014.1 Globally, the 
prevalence of DM was estimated to be 2.8% 
in 2000 and 4.4% in 2030. The total number 
of people with DM worldwide is projected to 
rise from 171 million in 2000 to 366 million 
in 2030.2 
Diabetic nephropathy is a common 
complication in patients with DM. It is the 
leading cause of chronic kidney disease in 
patients starting renal replacement therapy 
and associated with increased cardiovascular 
mortality.3 The prevalence of diabetic nephro-
pathy is approximately 20 to 30% in type 2 
DM during their lifetime.4 Progression of 
nephropathy was strongly associated with 
higher subsequent medical care costs in 
hypertensive patients with DM. Patients 
with normoalbuminuria who progressed to 
microalbuminuria experienced an annualized 
change in baseline costs that was USD 396 
higher significantly than those who maintained 
normal albuminuria (USD 902 versus USD 
506). In microalbuminuria group, progression 
was associated significantly with USD 747 
difference in annualized change in outpatient 
costs compared with no progression (USD 
1,056 versus USD 309). Its costs were 37% 
significantly higher following progression 
from normoalbuminuria to microalbuminuria 
(USD 10,188 vs. USD 7,424).5 
Limited information on laboratory test 
to detect microalbuminuria might lead to 
an impact on delay in diagnosis of diabetic 
nephropathy. Microalbuminuria screening 
in patients with DM is required to detect the 
diabetic nephropathy as early as possible and 
to avoid end stage renal disease (ESRD).6  
Common tests considered for chronic 
kidney disease (CKD) include urine albumin 
testing and creatinine-derived estimates of 
glomerular filtration rate (GFR). The tests can 
be conducted in order to  slow the progression 
of kidney disease, to prevent ESRD and to 
reduce the risk of cardiovascuar disease. 
Moreover, in patients with type 2 DM, the 
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tests are performed for the purposes of 
screening, diagnosis and monitoring response 
to treatment. 
The CKD might be occured without 
increasing albuminuria in patients with type 
2 DM. Therefore, both GFR and albuminuria 
testing are important tests in screening, 
diagnosis and monitoring of the patients. 
Albuminuria testing may be conducted 
by measurement of the albumin excretion 
rate (AER) or the albumin-creatinine ratio 
(ACR).7however, random\\nurine samples can 
be used.\\nMeasurement of urinary albumin 
can be influenced by a number of factors\\
nincluding: - urinary tract infection,\\n- 
high dietary protein intake,\\n- congestive 
heart failure,\\n- acute febrile illness,\\n- 
menstruation or vaginal discharge,\\n- 
water loading, and\\n- drugs (NSAIDS, 
ACEi Another albuminuria testing is total 
protein-creatinine ratio (TPCR) of random 
or spot urine sample.8-10 The measurement 
of TPCR on random (‘spot’) urine samples 
well correlates with 24-h total protein and 
albumin excretion. It is reported that TPCR is 
more sensitive than ACR to predict clinically 
relevant proteinuria. It has sensitivity and 
specificity of 94% and 88% respectively at 
the threshold of 100 mg/mmol.9 The protein-
creatinine ratio on a random urine sample 
provides evidence to “rule out” the presence 
of significant proteinuria as defined by a 
24-h urine excretion measurement.10 The 
advantages of this examination using spot 
urine samples, making it more practical and 
shorter examination time. The examination 
is influenced by several factors such as 
infections, high-protein diet, pregnancy and 
physical activity, hepatic dysfunction and 
congestive heart failure.11 
In Indonesia, especially in the Yogyakarta 
Special Region, the use of TPCR for 
the diagnosis of diabetic nephropathy 
in patients with type 2 DM has not been 
routinely performed. Therefore, this study 
was conducted to evaluate the diagnostic 
performance of TPCR to detect the present of 
microalbuminuria in patients with type 2 DM.
MATERIALS AND METHODS
Subjects
The subjects selected with the inclusion 
criteria were patients with type 2 DM 
suspected diabetic nephropathy (DM over 4 
years), and agreed to participate in this study. 
The subject who suffer either from urinary 
tract infection, or congestive heart failure, or 
hepatic dysfunction, or multiple myeloma, or 
microangiopathy hemolytic anemia (MAHA), 
or pregnancy, or incomplete data were 
excluded from the study.
Procedure
Laboratory tests were carried out for 2 
days in Clinical Laboratory of Dr. Sardjito 
General Hospital, Yogyakarta. In the 1st day, 
samples were taken for fasting blood glucose, 
2 hours post prandial blood glucose, HbA1c, 
and spot urine. Fasting blood glucose tests, 
2 hours post prandial blood glucose and 
HbA1c were measured from 2 mL of venous 
blood sample and the tests were conducted 
in the same day of sampling. Subjects on the 
1st day was also asked to collect 5 mL urine 
sample for urine albumin and creatinine 
measurements. Urine samples were then 
transferred into eppendorf tubes using a 
standardized micropipette, then labeled and 
kept at -20°C, pooled up to sufficient number 
of samples were accomplished. Subjects were 
also given written and oral instruction for 24 
hours urine collection (when collection began, 
first urination was discarded then second and 
subsequent urination collected for 24 hours) 
into a 2,500 mL threaded cap bottle urine 
container.
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On the 2nd day, 24 hours urine samples 
were collected. The collected 24-hour urine 
samples were homogenized by flipping the 
bottles as much as 5 times, after which the urine 
volume was recorded. Most homogeneous 
urine samples were transferred into eppendorf 
tubes using a standardized micropipette, then 
labeled and stored at -20°C, pooled until urine 
albumin tests performed after certain number 
of samples were collected. Fasting and 2 
hours post prandial blood glucose level were 
measured according to hexokinase method. 
Hemoglobin A1c (HbA1c) was measured 
with chromatography method. Both urine 
albumin and total protein were measured 
using an immunoturbidimetric method. Urine 
creatinine was measured using Jaffe method.
Albumin excretion rate is urinary albumin 
excretion within 24 hours and measured 
using immunoturbidimetric method. The 
AER is the refference standard to assess 
microalbuminuria. In this study, diabetic 
nephropathy was defined by AER value of ≥30 
mg/24 hours. The TPCR manually calculated 
by dividing the total value of urine protein and 
urine creatinine, the results expressed in mg/g. 
In this study diagnosis diabetic nephropathy 
was established if TPCR value equal or more 
than 150 mg/g.8 
Data analysis
Independent t-tests was used to test 
difference in mean age, fasting blood glucose, 
2 hours post prandial blood glucose when 
data distribution was normal and the Mann-
Whitney test if data distribution was not 
normal. Chi-Square test was applied to test the 
difference in proportions. The significance of 
the result set when p value was less than 0.05 
with a confidence interval of 95%. Data were 
analyzed using 2 X 2 table and the results were 
expressed in sensitivity (Sn), specificity (Sp), 
accuracy, positive predictive value (PPV), 
negative predictive value (NPV), likelihood 
ratio positive and negative, and accuracy.
Ethical consideration
The protocol of the study was approved 
by the Medical and Health Research Ethics 
Committee, Faculty of Medicine, Universitas 
Gadjah Mada, Yogyakarta.
RESULTS
This study involved 86 patients with type 
2 DM that consisted of 40 males (46.5%) and 
46 females (53.5%). Average age was 60.5 
years, and there were 43 subject that less than 
60 years old. Characteristics of the subjects 
completely could be seen in TABLE 1.






≤ 60 year 43 50.0
> 60 year 43 50.0
Education
Elementary School 9 10.0
Junior High School 6  6.3





Government employees 7 7.5
Private employees 3 2.5
Entrepreneur 7 7.5
Others 45 55.0
Group of diabetic nephrophaty was not 
significantly different from non diabetic 
group according to body mass index, blood 
pressure, hypertension status, heart disease, 
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dyslipidemia status, stroke, duration of 
DM, fasting blood glucose level, 2 hours 
post-prandial blood glucose level, mean of 
creatinine serum level as well as HbA1c level. 
Mean of TPCR level in diabetic nephropathy 
group was 248.07 mg/g. It was significantly 
higher than non diabetic nephropathy group 
namely 103.52 mg/g. In addition, mean of 
AER level in diabetic nephropath y group was 
205.37 mg/g which also significantly higher 
than that in diabetic nephropathy group, 24.59 
mg/g (TABLE 2).
TABLE 2. Comparison of variables among diabetic nephropathy and non diabetic nephropathy
Variable DN (n=77) Non DN (n=9) p
Body Mass Index (mean ± SD) 24.86 ± 3.37 25.24 ± 2.81 0.790
Hypertension [n (%)] 
Yes 45 (58.4) 3 (33.3)
1.000
No 32(41.6) 6 (66.7)
Heart disease [n (%)]
Yes 26 (33.8) 3 (33.3)
0.384
No 51 (66.2) 6 (66.7)
Dislipidemia [n (%)]
Yes 50 (64.9) 5 (55.6)
0.659
No 27 (35.1) 4 (44.4)
Stroke [n (%)]
Yes 7 (9.1) 2 (22.2)
0.133
No 70 (90.9) 7 (77.8)
Duration of DM (mean±SD years) 9.95 ± 7.56 6.0 ± 2.68 0.168
Blood Pressure (mean±SD mmHg)
Systole 126.12 ± 11.67 125.00 ± 10.49 0.824
Diastole 77.69 ± 7.17 80.00 ± 5.48 0.450
Fasting Blood Glucose (mean±SD mg/dL) 156.46 ± 59.46 139.83 ± 17.95 0.501
Blood Glucose 2HPP (mean±SD mg/dL) 232.19 ± 85.65 195.17 ± 52.09 0.306
Serum creatinine (mean±SD) 1.10 ± 0.23 0.87± 0.15 0.630
HbA1c (mean±SD %) 7.97 ± 2.21 7.67 ± 0.68 0.891
TPCR (mean± SD mg/g) 248.07 ± 136.29 103.52 ± 35.07 0.002
AER (mean± SD mg/24 hours) 205.37 ± 134.32 24.59 ± 3.05 0.000
Note: DN = diabetic nephropathy; Non DN = non diabetic nephropathy
Less, equal or more than 150 mg/g 
comparison TPCR versus AER to detect 
diabetic nephropathy gave 75 true positive 
result and 9 true negative result. This 
comparison gave rise to two false positive 
result. Sensitivity and specificity of TPCR 
to diagnose diabetic nephropathy were 
respectively 97.4% and 100%. TPCR had PPV 
of 100% and NPV 81.8%. In overall TPCR 
had accuracy of 97.7% to diagnose diabetic 
nephropathy (TABLE 3).
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TABLE 3. Analysis of performance diagnosis TPCR with gold standard AER
Performance of TPCR Value 95% CI
Sensitivity (%) 97.4 93.3 – 100.0
Specificity (%) 100.0 95.0 – 100.0
Positive predictive value (%) 100.0 95.0 – 100.0
Negative predictive value (%) 81.8 65.0 – 89.7
Accuracy (%) 97.7 91.0 – 100.0
Likelihood ratio positive /LR (+) ~ ~
Likelihood ratio negative/LR(-) 0.03 0.01 – 0.1
DISCUSSION
Asymptomatic proteinuria is a sign 
of the beginning of diabetic nephropathy, 
occurs intermittently for several years and 
finally settled with massive proteinuria. In 
the beginning stages, mild proteinuria of 
diabetic nephropathy is difficult to distinguish 
with proteinuria due to membranous 
glomerulonephritis because of other reasons. 
Proteinuria is an indicator of diabetic 
nephropathy, but other causes must be ruled out 
such as congestive heart failure, pyelonephritis 
including physiological state and orthostatic.10 
The TPCR is a quotient between urinary 
protein and urinary creatinine in units of mg/g 
creatinine. This ratio is developed in order 
to reduce the problem of variability volume 
and urine concentration, and it reflects renal 
excretory function and creatinine levels are 
relatively stable, although the number of urine 
excreted low or high.12 
Sensitivity TPCR to diagnose diabetic 
nephropathy is 97.4%. It means that this test 
has ability to detect 97.4% out of patient 
suffer from diabetic nephropathy. The test is 
able to detect all of non diabetic nephropathy 
since it has specifity of 100%. The PPV of 
100% means that the probability of a person 
truely suffer from diabetic nephropathy is 
100% when TPCR level is equal or more than 
150 mg/g. The NPV is 81.8% means that the 
probability of a person realy not suffer from 
diabetic nephropathy is 81.1% whenever 
value of TPCR is less than 150 mg/g. The 
study gives result where the specificity is 
higher than sensitivity so that this TPCR test 
is better use to rule in diabetic nephropathy 
among patients with type 2 DM. It is also 
supported the result of likelihood ratio since 
both likelihood ratio for test positive and 
negative are far from value of one. It will give 
rise to biger changes between pre and post-
test probality. 
The cut-off in this study was based on a 
recommendation of AACE/ACE 2015 which 
states the value of microalbuminuria set using 
TPCR value in the range of 150-500 mg/g. It 
was also based on research by Hashemapour 
et al.,11 using a cut-off of 150 mg/g.8,11 
Hashemapour et al.,11 report that TPCR had 
sensitivity of 94.5% and a specificity of 
78.2%. Another study conducted in Japan 
by Yamamoto et al.,13 which involved 1,033 
outpatients to detect microalbuminuria with 
TPCR using 150 mg/g as the cut-off. They 
reported that TPCR has sensitivity of 94.4 % 
and specificity of 86.1% to diagnose diabetic 
nephropathy.13 The difference  with this study 
was that they recruited the larger number 
of subject and conducted in a population of 
patients with cardiovascular risk factors.
Atkins et al.14 conducted a research to 
investigate sensitivity and specificity of TPCR 
to diagnose diabetic nephropathy. There were 
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10,596 subjects recruited and the average age 
was more than 40 years old. The result of 
the study showed that TPCR had sensitivity 
and specificity of 91.7% and 95.3% at a cut-
off of 0.20 mg/mg. The study differed from 
our study because they used more sample 
size, different cut-off and used timed urine 
samples.14 Yadav et al.,15 conducted a similar 
research in Nephal that involved 144 subjects 
where TPCR test was compared with AER as 
reference standard. They found that TPCR test 
had sensitivity and specificity of 96.6% and 
74.4% at a cut-off of 150 mg/g.15
Bukhari et al.,14 conducted a similar 
research in Faisalabad which involved 134 
patients with type 2 DM whose age more than 
40 years old. They reported that TPCR with a 
cut-off of 150 mg/g had a sensitivity of 95.2% 
and a specificity of 76.5% as compared with 
urine protein 24 hours to diagnose diabetic 
nephropathy. This research was different from 
our study since they recruited bigger number 
of subject so that the bias can be minimized. 
The TPCR examination had shown be more 
practical, time-saving and more convenient 
for patients.16 In addition to the parameters 
proteinuria, there are some markers that can 
be used to rule out the diagnosis of diabetic 
nephropathy include: cystatin C, urine 
transferrin and proteomics. Serum cystatin 
C is a marker of renal function better than 
serum creatinine concentration and significant 
predictor of the development of end-stage 
renal failure compared with GFR. Cystatin 
C is filtered almost completely reabsorbed in 
the proximal tubule, with almost no tubular 
secretion of cystatin-C. Thus, increase 
cystatin-C in urine, indicates renal tubular 
damage rather than just damage to the 
glomerulus. In addition, cystatin-C urine will 
increase with the high degree of albuminuria 
and achieve a higher level macroalbuminuria 
in patients with DM.17
CONCLUSIONS 
Laboratory examination of TPCR at 
level of equal or more than 150 mg/g, has 
sensitivity, specificity, positive predictive 
value, negative predictive value, and accuracy 
of 97.4%, 1000.%, 100.0%, 81.8%, and 97.7%, 
respectively to diagnose diabetic nephropathy 
in patients with type 2 DM. Therefore, it could 
be used as an alternative whenever laboratory 
examination of AER unlikely to be done.
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